Rave RTSM – Even the Most Complex Trials Reach Milestones Faster
Through a simple, 100% configurable interface and unification with Rave EDC within the Medidata Platform, RTSM has robust functionality to support both simple and complex study designs. RTSM reduces timelines and eases mid-study changes while ensuring a single source of truth for your clinical and medical device trials.
From complex randomization and adaptive trials to Direct-to-Patient and repeating visit cycles, when you choose Rave RTSM you have immediate access to all current and future features available for your study.
Benefits of Rave RTSM
Unification of Rave RTSM and Rave EDC
Rave RTSM is fully unified with Rave EDC with no customized integrations, no reconciliation required and is fully configurable and pre-validated. The Rave RTSM and EDC solution is a paradigm shift from IRT/EDC as separate vendor systems. Sites record patient visits in Rave EDC as Rave RTSM assigns randomization arms and inventory items in real time. There is no need for double entry which increases the overall data integrity and reduces risk.
Abbreviated Timelines
Rave RTSM can be configured and implemented in as little as 2 weeks. Its pre-validated capabilities enable a quick UAT with reduced risk.
For mid-study changes, study builders can modify the study using RTSM’s state of the art Edit Live Design which enables changes to occur in real-time without stopping enrollment.
Shorten the Duration from LPI to Database Lock
Rave RTSM and Rave EDC are completely unified meaning there are no customized integrations reducing risk and timelines.
Data between RTSM and EDC requires no reconciliation as is required for a separate IRT and EDC model. This enables studies to lock much quicker, resulting in considerable cost savings.
Reduction of Risk
Rave RTSM is configurable and pre-validated. This means that RTSM works the same for all studies. What differs from one study to the next are the configuration settings of Randomization, Dispensation and Supply Management. With RTSM, User Acceptance Testing (UAT) is abbreviated with a smaller percentage of findings.
RTSM solution’s reduced risk is the biggest differentiator against all other IRT vendors.
Complex Trials and RTSM: Managing the ‘Known Unknowns’
Key Capabilities
Leading the competition with next-generation reporting and analytics
Real-time visibility into enrollment, randomization and supply enabling real-time decision making on needs to increase/decrease supply at site while minimizing waste. Custom reports and dashboards enable visualization of data through charts, graphs, plots and maps.
Unparalleled Experience and Expertise in RTSM
Medidata’s Professional Services RTSM team of experts has countless years of clinical trial experience and a deep understanding of the IRT / RTSM industry. We partner with you every step of the way to ensure your RTSM processes are optimized so you can achieve the highest value. Support can range from full build and execution to Live Study Management™, which allows you to have an experienced IRT SME who can support unblinded trial supply management activities during study conduct phase. Among the benefits include guiding you towards the most impactful supply strategy to meet your goals.
Robust Supply Management Tools
Rave RTSM’s supply management capabilities and real-time visibility provide the data and analysis to ensure supply optimization. RTSM’s supply plans offer the height of flexibility to make real-time decisions on supply planning. RTSM integrates with the industry’s largest depots, which ensures expedited shipping. Cross-study reporting, drug pooling and forecasting are just some examples of how to accomplish your supply chain objectives.
Build and Execute Complex Adaptive Trials Quickly and Efficiently
Rave RTSM has the flexibility to quickly and seamlessly adapt to changes in clinical trial designs using pre-validated randomization and trial supply solutions that can be configured in minutes. Complex adaptive, cohort, umbrella and basket trials are easier to build while mid-study changes can be made in minutes with no down time or change orders. Expedite study adaptations quicker across products on the Medidata Platform.
Ease and Flexibility to Execute Direct-to-Patient (DtP) in Real-time
Rave RTSM has unsurpassed DtP capabilities giving sponsors and CROs the highest level of flexibility for decentralized and hybrid trials. DtP can be enabled for any combination of sites and visits and provides sites the ability to determine the source of the patient’s dispensation.
In addition, only the Medidata Platform is truly virtualized allowing patients to confirm incoming shipments using the myMedidata App.